TGM7 and breast carcinoma: The pyrrolidinedione compound EP13, that is not only an unsaturated but also a desulfurized and deoxygenated derivative of TGZ, induced early OXPHOS inhibition in the three breast cancer cell lines with a higher efficiency than its parent compounds TGZ and Δ2-TGZ.